An fNIRS Study of Motor Cortical Activation in Stoke Patients
NCT ID: NCT05376098
Last Updated: 2022-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2022-02-01
2024-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Neurological Trajectory and Clinical Outcomes in Brain Acute Ischemic Stroke
NCT06170086
Early Neurological Deterioration in Patients With Acute Ischemic Stroke
NCT03703986
Stroke Imaging Package Study
NCT02485275
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215
A Longitudinal Study of Multimodal Resonance Imaging in Stroke Patients
NCT02024503
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years old≤ age ≤ 75 years old.
* Cerebral ischemic stroke onset within 7 days.
* First onset.
* Upper limb motor dysfunction.
Exclusion Criteria
* Complicated with other diseases in the nervous system.
* Combined with other serious disease states: circulatory system, respiratory system,
* motor system diseases, such as atrial fibrillation, heart failure, lung infection, severe liver and kidney dysfunction, lower limb venous thrombosis, etc.
* Upper limb dysfunction caused by other reasons, such as fractures, upper limb deformities, etc.
* Contraindicated to imaging tests, such as metal implantation, claustrophobia, and severe obesity.
* Those who cannot complete the examination due to other reasons, such as mental disorders, cognitive dysfunction, etc.
* Other causes: alcoholism; pregnancy; skull defects; soft tissue injuries at the site of examination; visual impairment, etc.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xuanwu Hospital, Beijing
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Junwei Hao
Role: PRINCIPAL_INVESTIGATOR
Xuanwu Hospital, Beijing
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xuanwu Hospital, Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Junwei Hao, M.D.,Ph.D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
haojunwei7
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.